The data depicts the top 15 pharmaceutical products by sales worldwide in 2017. In that year, Bristol-Myers Squibb's pharmaceutical product Opdivo was ranked 14th, with global sales of some 4.95 billion USD. The top product was Abbvie's Humira, generating more than 18.4 billion dollars. Humira is a drug used for especially for the treatment of rheumatoid arthritis.
Humira | 18427 |
Rituxan | 9238 |
Revlimid | 8187 |
Enbrel | 7885 |
Herceptin | 7441 |
Eliquis | 7395 |
Remicade | 7152 |
Avastin | 7096 |
Xarelto | 6589 |
Eylea | 6034 |
Lantus | 5732 |
Prevnar 13 | 5601 |
Lyrica | 5065 |
Opdivo | 4948 |
Neulasta | 4723 |